Boston Scientific Corp
(MIL:1BSX)
€
85.5
0 (0%)
Market Cap: 126.98 Bil
Enterprise Value: 135.61 Bil
PE Ratio: 74.26
PB Ratio: 6.39
GF Score: 56/100 Boston Scientific Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022 / 01:15PM GMT
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst
Good Morning. I'm happy to kick off day 3 here with Boston Scientific. I'm Robbie Marcus, medtech analyst at JPMorgan. Very happy to introduce Mike Mahoney, the CEO of Boston Scientific. And afterwards in Q&A, we're going to have Dan Brennan and Lauren Tengler join us as well. But with that, Mike, I see you're in San Fran. You're ready to go.
Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO
I am.
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst
I'll hand it off to you.
Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO
We're planting the flag in support of your meeting here. Well, thank you, Robbie. As you know, it's a -- we feel honored to help represent Boston Scientific at this JPMorgan conference.
For those who are less familiar with it, it's a very exciting company, very innovative, focused
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot